Company profile
UK company 06132283, incorporated on 1 March 2007.
Disruptive Innovation to Combat Antimicrobial Resistance | Procarta Biosystems
Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative new oligonucleotide-based antimicrobials.
Company number 06132283
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
1 Mar 2019 to 28 Feb 2021
"Procarta Biosystems is an antibiotic drug discovery and development organisation with a unique platform that can identify new targets for antibiotics as well as discovering new drugs to kill even the most resistant bacteria. Procarta has discovered a new type of antimicrobial that kills bacteria by blocking their gene expression through a novel mechanism...
1 Apr 2018 to 31 Mar 2019
"Procarta is an antimicrobial drug discovery and development organisation with a unique platform that is developing a new type of antimicrobial: opening up bacterial transcription as a novel target. The proprietary antimicrobials are short fragments of DNA that invade the bacterial cell and kill by blocking gene expression through a novel mechanism of int...
1 Feb 2018 to 31 Jan 2019
Awaiting Public Project Summary
1 Dec 2013 to 30 Nov 2014
Procarta is developing a lasting solution to the treatment of bacterial infections using a proprietary technology platform based on nanoparticulate oligonucleotide therapeutics. This project will enable better understanding of how to formulate and manufacture novel nanoparticulate antibacterials, define and fix key QC parameters, leading to a production p...
1 Mar 2013 to 30 Jun 2013
Procarta is developing a lasting solution to the treatment of bacterial infections using a proprietary technology platform based on nanoparticulate oligonucleotide therapeutics. This project will enable better understanding of how to manufacture the delivery nanoparticles, define and fix key QC parameters, leading to a production process for scale up. Thi...
1 Nov 2012 to 31 Mar 2013
Procarta is investigating how safe and effective changes to the bacterial content in the human gut can reduce adverse side effects associated with the typical Western diet.
